@article{f11f7094a1e34eddbc5f53540bfb3ea2,
title = "Natriuretic peptides: Renal protective after all?",
keywords = "atrial natriuretic peptide, cardiac surgery, chronic kidney disease, natriuretic peptide",
author = "Guido Boerrigter and Burnett, {John C.}",
note = "Funding Information: This work is supported by National Institutes of Health grants HL36634 and HL76611 . Dr. Boerrigter has reported that he has no relationships relevant to the contents of this paper to disclose. Dr. Burnett is Chair of the Nile Therapeutics Scientific Advisory Board, and Mayo has licensed cenderitide to Nile Therapeutics. ",
year = "2011",
month = aug,
day = "23",
doi = "10.1016/j.jacc.2010.12.053",
language = "English (US)",
volume = "58",
pages = "904--906",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "9",
}